Navigation Links
Bradmer provides Phase III Neuradiab trial update and guidance
Date:10/15/2007

TSX: BMR

TORONTO, Oct. 15 /PRNewswire-FirstCall/ - Bradmer Pharmaceuticals Inc., a biopharmaceutical company dedicated to the development and commercialization of cancer therapies, today announced that it held a pre-Phase III meeting with the U.S. Food and Drug Administration (FDA) at which the FDA concurred with Bradmer's proposed design of the Phase III trial for its lead drug, Neuradiab, a treatment for newly diagnosed glioblastoma multiforme (GBM), the most common form of brain cancer.

At the recent meeting, the FDA responded favorably to the Company's presentation of its full clinical plan which included the trial protocol, standard operating procedures, statistical plan, and related documents.

"We initiated this discussion with the FDA to establish clarity around the appropriate clinical structure of a multicenter trial that would be suitable for the potential registration of Neuradiab," commented Alan M. Ezrin, Ph.D., President and Chief Executive Officer of Bradmer. "We are delighted with the FDA's response to the presentation of our clinical plans, which were developed in conjunction with the FDA, with our collaborators at Duke University and with thought leaders in neurooncology and neurosurgery."

Bradmer and the FDA discussed and agreed to the study trial design which includes an enhanced statistical power calculation of 90% and an added interim efficacy analysis. The agreed design, which will allow for the enrollment of approximately 380 patients in each of the experimental and control arms, has the possibility to actually shorten the study trial duration and to improve the statistical probability of success. Bradmer anticipates a 24-month enrollment period and an interim efficacy analysis on overall survival at approximately month 39 post-trial initiation, or at 470 mortality events. Should an additional efficacy analysis be required, it would occur at 626 events.

Prior to the initiatio
'/>"/>

SOURCE Bradmer Pharmaceuticals Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Protein provides antioxidant protection to Neurons
2. Acupuncture provides relief
3. Micro-camera provides new breast imaging technique
4. Hormone therapy provides no heart benefit
5. MicroRNA provides new insight into birth defects
6. Drug Spironolactone Provides Renal And Cardioprotection In Diabetic Patients
7. Neurobiology Provides Answers To Block Memory-Related Drug Cravings
8. Cholesterol provides immunity against infection by certain parasites
9. John Hopkins CGHH program provides Global Health education
10. London Hospital Provides Specialized Care For Pregnant Women
11. Hope Lodges provides free stay to cancer patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... 23, 2013 Funeral Financials is encouraging ... to the EOD Memorial Foundation Funeral Financials ... greatest victims from the war. , According to ... 1941 before the U.S. was even at war. ... identified with the Explosive Ordnance Disposal Badge. EOD technicians ...
(Date:5/23/2013)... Da Vinci surgical robot maker Intuitive Surgical ... State May 23, according to Bloomberg.* The Rottenstein Law ... lawsuits , expresses disappointment in the ruling but encourages ... read a single verdict as representative of all da ... Taylor v. Intuitive Surgical Inc.; 09-2-03136-5, Superior Court, Port ...
(Date:5/23/2013)... Mann HealthDay Reporter , , THURSDAY, May 23 ... take to help treat hip and knee osteoarthritis may ... for developing glaucoma, a small new study of older ... an increase of intraocular pressure (IOP) or pressure inside ... leading causes of blindness. In the ...
(Date:5/23/2013)... THURSDAY, May 23 (HealthDay News) -- People who eat ... they realize -- and teens are the worst offenders, ... of calories in their meals by as much as ... as 23 percent, and adults by as much as ... in a news release from the Robert Wood Johnson ...
(Date:5/23/2013)... a woman harried by hot flashes says she,s having ... online in Menopause , the journal of The ... tests that what these women say about their memory ... that hot flashes were related to memory problems, and ... was a relationship between hot flashes and what women ...
Breaking Medicine News(10 mins):Health News:Funeral Financials Asks Americans to Donate their Memorial Day Beer Money to Help EOD Scholarship 2Health News:Funeral Financials Asks Americans to Donate their Memorial Day Beer Money to Help EOD Scholarship 3Health News:Da Vinci Surgical Robot Lawsuit News: Rottenstein Law Group LLP Comments on Intuitive Win in Negligent Training Trial 2Health News:Glucosamine Supplements Tied to Risk of Eye Condition 2Health News:Glucosamine Supplements Tied to Risk of Eye Condition 3Health News:How Many Calories in Your Fast-Food Meal? Guess Again 2
... NASHVILLE, Tenn. and GLEN ROCK, N.J., Aug. 6 ... of surveyed pharmacy directors say that by 2014 they ... preferred biologic for all immune conditions, such as rheumatoid ... the new Formulary Forum report entitled Formulary Advantages ...
... , , , , ... growing social network for physicians , announced today the addition ... to its leadership team. Mr. Chase joins iMedExchange as Vice President ... Pharmaceutical, Medical Device and Luxury Goods and Services companies. , ...
... , , JACKSONVILLE, Fla., Aug. ... most important of the five senses. Yet, new research reveals that across ... translates to good eye health. This and other findings confirm a large ... people from seeking proper treatment and diagnosis for them and their children. ...
... , , NEW YORK, Aug. 6 ... technology shown to significantly help improve the appearance of unwanted discoloration, ... through select physicians to help their patients achieve picture perfect skin. ... found in leading physician offices for $120 per 1 ounce pump. ...
... - Not for Release, Publication or Distribution Directly or Indirectly in, ... any Other Jurisdiction in Which Such Publication or Distribution ... is not a Prospectus and is not an Offer to Sell or a, ... United States or, in any Other Jurisdiction, , ...
... , , , ... ) today announced that its Board of Directors has named Daniel J. ... He will join Stereotaxis in September, 2009 and replace James M. ... Company effective at year end 2009. Mr. Johnston brings over 15 ...
Cached Medicine News:Health News:U.S. Payers Intend to Limit Preferred Coverage to Only One Immune Biologic 2Health News:U.S. Payers Intend to Limit Preferred Coverage to Only One Immune Biologic 3Health News:Former Microsoft Healthcare Executive Joins iMedExchange 2Health News:Worldwide Gap Between Vision Care Attitudes & Behavior 2Health News:Worldwide Gap Between Vision Care Attitudes & Behavior 3Health News:Worldwide Gap Between Vision Care Attitudes & Behavior 4Health News:Worldwide Gap Between Vision Care Attitudes & Behavior 5Health News:Photos: Lumixyl(TM) Enters the Market to Improve the Appearance of Hyperpigmentation without Irritation and Side Effects 2Health News:Photos: Lumixyl(TM) Enters the Market to Improve the Appearance of Hyperpigmentation without Irritation and Side Effects 3Health News:EANS-News: Alapis Announces its Share Capital Increase to Raise c. EUR 451.1 million 2Health News:EANS-News: Alapis Announces its Share Capital Increase to Raise c. EUR 451.1 million 3Health News:Stereotaxis Names Daniel Johnston as Chief Financial Officer 2Health News:Stereotaxis Names Daniel Johnston as Chief Financial Officer 3
(Date:5/23/2013)...  The need to add tissue preserving therapies ... prominently at the 108 th Annual Meeting ... Diego.  According to SonaCare Medical, a leader in ... the need for image-guided technologies to better identify ... minimally invasive ablative treatments, was addressed in the ...
(Date:5/23/2013)... 23, 2013  Every day, their baby stopped breathing, his ... lungs. April and Bryan Gionfriddo watched ... "Quite a few doctors said he had a ... April Gionfriddo , about her now 20-month-old son, ... work, we would take it and run with it." ...
(Date:5/23/2013)... Mass. , May 23, 2013  Hologic, ... HOLX ), a leading developer, manufacturer and supplier ... products, with an emphasis on serving the healthcare ... large-scale observational study in a U.S. clinical practice ... technology (breast tomosynthesis) with conventional 2D mammography alone ...
Breaking Medicine Technology:Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 2Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 3Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 4Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 5Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 6Baby's life saved with groundbreaking 3D printed device from U-M that restored his breathing 2Baby's life saved with groundbreaking 3D printed device from U-M that restored his breathing 3Baby's life saved with groundbreaking 3D printed device from U-M that restored his breathing 4First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection 2First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection 3First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection 4
... , , , , , , CAPUA, ... has entered into an agreement with Laboratoires Mayoly Spindler, Chatou ... has successfully completed process development and commenced cGMP manufacture of ... clinical needs. DSM BioSolutions manufactures the lipase compound at its ...
... , ALISO VIEJO, Calif., Dec. 21 Clarient, Inc. (Nasdaq: ... pathologists, oncologists and the pharmaceutical industry, today announced that it ... in an all-stock merger valued at up to $17.6 million, ... agreement are successfully met. As a result of the ...
Cached Medicine Technology:DSM to Manufacture 'MS1819' Lipase Compound for Mayoly Spindler 2DSM to Manufacture 'MS1819' Lipase Compound for Mayoly Spindler 3DSM to Manufacture 'MS1819' Lipase Compound for Mayoly Spindler 4Clarient Acquires Applied Genomics, Inc. 2Clarient Acquires Applied Genomics, Inc. 3Clarient Acquires Applied Genomics, Inc. 4Clarient Acquires Applied Genomics, Inc. 5Clarient Acquires Applied Genomics, Inc. 6Clarient Acquires Applied Genomics, Inc. 7
Ultra-Slip™ endotracheal tube guide for single-patient use only., ,Caution: Not MRI Compatible....
FlexiSlip™ Plastic coated malleable metal core. Single use, Sterile, Latex Free. Soft distal tip flexes to reduce risk of trauma to patient. Malleable metal core is easy to shape. Low friction ...
Endotracheal Tube Stylet- Adult, Copper, Malleable, Non-Sterile, Latex Free, Suitable for tubes 5.0 mm I.D. or larger....
... Prevent dental and soft tissue damage. Used ... X-ray. Light-guided intubation is based upon the ... neck. This technique takes advantage of the ... the esophagus. A well-defined, circumscribed glow can ...
Medicine Products: